Ultrasound-mediated micellar drug delivery

International Journal of Hyperthermia

Volumn 28, Issue 4, 2012, Pages 374-385

  Rapoport, Natalya ^a  

^a Department of Electrical and Computer Engineering   (United States)

Author keywords

Micelle biodistribution; Micelle stability; Passive drug targeting; Thermo responsive polymeric micelles; Ultrasound triggered drug release

Indexed keywords

DOXORUBICIN; LIPOSOME; NANOCARRIER; POLYMER;

ARTICLE; CELL MIGRATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXTRAVASATION; DRUG PENETRATION; DRUG RELEASE; DRUG RETENTION; DRUG SOLUBILITY; DRUG STABILITY; DRUG TARGETING; HUMAN; HYDROPHOBICITY; HYPERTHERMIA; IN VITRO STUDY; MICELLE; MOLECULARLY TARGETED THERAPY; NANOENCAPSULATION; NONHUMAN; TEMPERATURE DEPENDENCE; ULTRASOUND;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; MICELLES; POLYMERS; SOUND; ULTRASONIC THERAPY;

EID: 84861496586     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2012.665567     Document Type: Article

References (136)

1. Iyer AK, Khaled G, Fang J, Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 2006;11:812-818.
2. Campbell RB. Tumor physiology and delivery of nanophar-maceuticals. Anticancer Agents Med Chem 2006;6:503-512.
3. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, et al. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998;95:4607-4612.
4. Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011;63:136-151.
5. Bohner M, Ring TA, Rapoport N, Caldwell KD. Fibrinogen adsorption by PS latex particles coated with various amounts of a PEO/PPO/PEO triblock copolymer. J Biomater Sci Polym Ed 2002;13:733-746.
6. Tan JS, Butterfield DE, Voycheck CL, Caldwell KD, Li JT. Surface modification of nanoparticles by PEO/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats. Biomaterials 1993;14:823-833.
7. Bromberg L. Polymeric micelles in oral chemotherapy. J Control Release 2008;128:99-112.
8. Chiappetta DA, Sosnik A. Poly(ethylene oxide)-poly(propyl-ene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm 2007;66:303-317.
9. Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC. Block copolymer micelles: Preparation, characterization and application in drug delivery. J Control Release 2005;109:169-188.
10. Gaucher G, Marchessault RH, Leroux JC. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J Control Release 2010;143:2-12.
11. Kabanov AV, Alakhov VY. Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst 2002;19:1-72.
12. Kakizawa Y, Kataoka K. Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev 2002;54:203-222.
13. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv Drug Deliv Rev 2001;47:113-131.
14. Kedar U, Phutane P, Shidhaye S, Kadam V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 2010;6:714-729.
15. Lavasanifar A, Samuel J, Kwon GS. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 2002;54:169-190.
16. Mikhail AS, Allen C. Block copolymer micelles for delivery of cancer therapy: Transport at the whole body, tissue and cellular levels. J Control Release 2009;138:214-223.
17. Nishiyama N, Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 2006;112:630-648.
18. Osada K, Christie RJ, Kataoka K. Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery. J R Soc Interface 2009;6S3: S325-339.
19. Savic R, Eisenberg A, Maysinger D. Block copolymer micelles as delivery vehicles of hydrophobic drugs: Micelle-cell interactions. J Drug Target 2006;14:343-355.
20. Han X, Liu J, Liu M, Xie C, Zhan C, Gu B, et al. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: Preparation and evaluation in vitro. Int J Pharm 2009;372:125-131.
21. Torchilin VP. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci 2004;61:2549-2559.
22. Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B. Immunomicelles: Ttargeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA 2003;100:6039-6044.
23. Rapoport N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog Polym Sci 2007; 32:962-990.
24. Rapoport N. Stabilization and acoustic activation of Pluronic micelles for tumor-targeted drug delivery. Colloids Surf B Biointerfaces 1999;3:93-111.
25. Luo S, Xu J, Zhu Z, Wu C, Liu S. Phase transition behavior of unimolecular micelles with thermoresponsive poly(N-isopro-pylacrylamide) coronas. J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 2006;110:9132-9139.
26. Bonacucina G, Cespi M, Mencarelli G, Giorgioni G, Palmieri F. Thermosensitive self-assembling block copoly-mers as drug delivery systems. Polymers 2011;3:779-811.
27. Letchford K, Zastre J, Liggins R, Burt H. Synthesis and micellar characterization of short block length methoxy poly(ethylene glycol)-block-poly(caprolactone) diblock copol-ymers. Colloids Surf B Biointerfaces 2004;35:81-91.
28. Alexandridis P, Holzwarth JF, Hatton TA. Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: Thermodynamics of copolymer association. Macromolecules 1994;27:2414-2425.
29. Alexandridis P, Nivaggioli T, Hatton TA. Temperature effects on structural properties of Pluronic P104 and F108 PEO-PPO-PEO block copolymer solutions. Langmuir 1995;11:1468-1476.
30. Shuai X, Merdant T, Schaper A, Xi F, Kissel T. Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconj Chem 2004;15:441-448.
31. Matsumura Y, Gotoh M, Muro K, Yamada Y, Shirao K, Shimada Y, et al. Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunolipo-some, in patients with metastatic stomach cancer. Ann Oncol 2004;15:517-525.
32. Matsumura Y, Hamaguchi T, Ura T, Muro K, Yamada Y, Shimada Y, et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer 2004;91:1775-1781.
33. Danson S, Ferry D, Alakhov V, Margison J, Kerr D, Jowle D, et al. Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer 2004;90:2085-2091.
34. Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS, et al. Phase I and pharmacokinetic study of Genexol-PM, a Cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res 2004;10:3708-3716.
35. Fournier E, Dufresne MH, Smith DC, Ranger M, Leroux JC. A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers. Pharm Res 2004;21:962-968.
36. Le Garrec D, Gori S, Luo L, Lessard D, Smith D, Yessine Mea. Poly(n-vinylpyrrolidone)-block-poly(d,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: In vitro and in vivo evaluation. J Control Release 2004;99:83-101.
37. Hamaguchi T, Matsumura Y, Suzuki M, Shimizu K, Goda R, Nakamura I, et al. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br J Cancer 2005;92:1240-1246.
38. Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Wan Kim S, et al. In vivo evaluation of polymeric micellar paclitaxel formulation: Toxicity and efficacy. J Control Release 2001; 72:191-202.
39. Kim DW, Kim SY, Kim HK, Kim SW, Shin SW, Kim JS, et al. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol. 2007;18:2009-2014.
40. Kim JG, Sohn SK, Song HS, Kwon KY, Do YR, Lee KH, et al. Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol. 2007;60: 863-869.
41. Lee KS, Chung HC, Im SA, Park YH, Kim CS, Kim SB, et al. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res Treat 2008;108:241-250.
42. Saif MW, Podoltsev NA, Rubin MS, Figueroa JA, Lee MY, Kwon J, et al. Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer. Cancer Invest 2010;28:186-194.
43. Ponce AM, Vujaskovic Z, Yuan F, Needham D, Dewhirst MW. Hyperthermia mediated liposomal drug delivery. Int J Hyperthermia 2006;22:205-213.
44. Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999;15:345-370.
45. Dewhirst MW, Vujaskovic Z, Jones E, Thrall D. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia 2005;21:779-790.
46. Yarmolenko PS, Moon EJ, Landon C, Manzoor A, Hochman DW, Viglianti BL, et al. Thresholds for thermal damage to normal tissues: An update. Int J Hyperthermia 2011;27:320-343.
47. Vujaskovic Z, Kim DW, Jones E, Lan L, McCall L, Dewhirst MW, et al. A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer. Int J Hyperthermia 2010;26:514-521.
48. Yarmolenko PS, Zhao Y, Landon C, Spasojevic I, Yuan F, Needham D, et al. Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours. Int J Hyperthermia 2010; 26:485-498.
49. Gaber MH, Wu NZ, Hong K, Huang SK, Dewhirst MW, Papahadjopoulos D. Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys 1996;36:1177-1187.
50. Hauck ML, Coffin DO, Dodge RK, Dewhirst MW, Mitchell JB, Zalutsky MR. A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumour interstitial fluid pressure. Int J Hyperthermia 1997;13:307-316.
51. Hauck ML, Dewhirst MW, Bigner DD, Zalutsky MR. Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model. Clin Cancer Res 1997;3:63-70.
52. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res 2000;60:6950-6957.
53. Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res 2000;60:4440-4445.
54. Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature-sensitive liposome for use with mild hyper-thermia: Characterization and testing in a human tumor xenograft model. Cancer Res 2000;60:1197-1201.
55. Neradovic D, Soga O, Van Nostrum CF, Hennink WE. The effect of the processing and formulation parameters on the size of nanoparticles based on block copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide) with and without hydrolytically sensitive groups. Biomaterials 2004;25: 2409-2418.
56. Wei H, Zhang XZ, Cheng H, Chen WQ, Cheng SX, Zhuo RX. Self-assembled thermo-and pH responsive micelles of poly(10-undecenoic acid-b-N- isopropylacrylamide) for drug delivery. J Control Release 2006;116:266-274.
57. Wei H, Zhang X, Cheng C, Cheng SX, Zhuo RX. Self-assembled, thermosensitive micelles of a star block copolymer based on PMMA and PNIPAAm for controlled drug delivery. Biomaterials 2007;28:99-107.
58. Wei H, Zhang XZ, Zhou Y, Cheng SX, Zhuo RX. Self-assembled thermoresponsive micelles of poly(N-isopropyla-crylamide-b-methyl methacrylate). Biomaterials 2006;27: 2028-2034.
59. Nakayama M, Okano T, Miyazaki T, Kohori F, Sakai K, Yokoyama M. Molecular design of biodegradable polymeric micelles for temperature-responsive drug release. J Control Release 2006;115:46-56.
60. Soga O, van Nostrum CF, Hennink WE. Thermosensitive and biodegradable polymeric micelles with transient stability. J Control Release 2005;101:383-385.
61. Soga O, van Nostrum CF, Fens M, Rijcken CJ, Schiffelers RM, Storm G, et al. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. J Control Release 2005;103:341-353.
62. Husseini GA, Christensen DA, Rapoport NY, Pitt WG. Ultrasonic release of doxorubicin from Pluronic P105 micelles stabilized with an interpenetrating network of N,N-diethyla-crylamide. J Control Release 2002;83:303-305.
63. Bae KH, Choi SH, Park SY, Lee Y, Park TG. Thermosensitive pluronic micelles stabilized by shell cross-linking with gold nanoparticles. Langmuir 2006;22: 6380-6384.
64. Agut W, Brulet A, Schatz C, Taton D, Lecommandoux S. pH and temperature responsive polymeric micelles and polymer-somes by self-assembly of poly[2-(dimethylamino)ethyl meth-acrylate]-b-poly(glutamic acid) double hydrophilic block copolymers. Langmuir 2010;26:10546-10554.
65. Bigot J, Charleux B, Cooke G, Delattre F, Fournier D, Lyskawa J, et al. Tetrathiafulvalene end-functionalized poly(N-isopropylacrylamide): A new class of amphiphilic polymer for the creation of multistimuli responsive micelles. J Am Chem Soc 2010;132:10796-10801.
66. Cai Y, Aubrecht KB, Grubbs RB. Thermally induced changes in amphiphilicity drive reversible restructuring of assemblies of ABC triblock copolymers with statistical polyether blocks. J Am Chem Soc 2011;133:1058-1065.
67. Cha MH, Choi J, Choi BG, Park K, Kim IH, Jeong B, et al. Synthesis and characterization of novel thermo-responsive F68 block copolymers with cell-adhesive RGD peptide. J Colloid Interface Sci 2011;360:78-85.
68. Chang C, Wei H, Wu DQ, Yang B, Chen N, Cheng SX, et al. Thermo-responsive shell cross-linked PMMA-b-P(NIPAAm-co-NAS) micelles for drug delivery. Int J Pharm 2011;420: 333-340.
69. Cui Q, Wu F, Wang E. Thermosensitive behavior of poly(ethylene glycol)-based block copolymer (PEG-b-PADMO) controlled via self-assembled microstructure. J Phys Chem B. 2011;115:5913-5922.
70. Kamiya N, Shiotari Y, Tokunaga M, Matsunaga H, Yamanouchi H, Nakano K, et al. Stimuli-responsive nano-particles composed of naturally occurring amphiphilic proteins. Chem Commun (Camb) 2009;35:5287-5289.
71. Li W, Li J, Gao J, Li B, Xia Y, Meng Y, et al. The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors. Biomaterials. 2011;32:3832-3844.
72. Mao J, Bo S, Ji X. pH/temperature-responsive behavior of amphiphilic block copolymer micelles prepared using two different methods. Langmuir 2011;27:7385-7391.
73. Naik SS, Ray JG, Savin DA. Temperature-and pH-responsive self-assembly of poly(propylene oxide)-b-poly(lysine) block copolymers in aqueous solution. Langmuir 2011;27: 7231-7240.
74. Pavlukhina S, Sukhishvili S. Polymer assemblies for controlled delivery of bioactive molecules from surfaces. Adv Drug Deliv Rev 2011;63:822-836.
75. Safaei Nikouei N, Lavasanifar A. Characterization of the thermo-and pH-responsive assembly of triblock copolymers based on poly(ethylene glycol) and functionalized poly(epsi-lon-caprolactone). Acta Biomater 2011;7:3708-3718.
76. Strong LE, West JL. Thermally responsive polymer-nanopar-ticle composites for biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3:307-317.
77. Weiss J, Laschewsky A. Temperature-induced self-assembly of triple-responsive triblock copolymers in aqueous solutions. Langmuir 2011;27:4465-4473.
78. Yang L, Guo C, Jia L, Liang X, Liu C, Liu H. Dual responsive copolymer micelles for drug controlled release. J Colloid Interface Sci 2010;350:22-29.
79. Zhao C, He P, Xiao C, Gao X, Zhuang X, Chen X. Synthesis of temperature and pH-responsive crosslinked micelles from polypeptide-based graft copolymer. J Colloid Interface Sci 2011;359:436-442.
80. Hauck ML, LaRue SM, Petros WP, Poulson JM, Yu D, Spasojevic I, et al. Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin Cancer Res 2006;12:4004-4010.
81. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res 2000;60:6950-6957.
82. Gao Z, Fain HD, Rapoport N. Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. Mol Pharm 2004;1:317-330.
83. Gao ZG, Fain HD, Rapoport N. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J Control Release 2005;102:203-222.
84. Gao Z, Lukyanov AN, Chakilam AR, Torchilin VP. PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing. J Drug Target 2003; 11:87-92.
85. Husseini GA, Myrup GD, Pitt WG, Christensen DA, Rapoport NY. Factors affecting acoustically triggered release of drugs from polymeric micelles. J Control Release 2000;69:43-52.
86. Husseini GA, Diaz de la Rosa MA, Gabuji T, Zeng Y, Christensen DA, Pitt WG. Release of doxorubicin from unstabilized and stabilized micelles under the action of ultrasound. J Nanosci Nanotechnol 2007;7:1028-1033.
87. Marin A, Muniruzzaman M, Rapoport N. Mechanism of the ultrasonic activation of micellar drug delivery. J Control Release 2001;75:69-81.
88. Marin A, Muniruzzaman M, Rapoport N. Acoustic activation of drug delivery from polymeric micelles: Effect of pulsed ultrasound. J Control Release 2001;71:239-249.
89. Marin A, Sun H, Husseini GA, Pitt WG, Christensen DA, Rapoport NY. Drug delivery in Pluronic micelles: Effect of high-frequency ultrasound on drug release from micelles and intracellular uptake. J Control Release 2002;84:39-47.
90. Rapoport N, Marin A, Christensen DA. Ultrasound-activated micellar drug delivery. Drug Delivery Syst Sci 2002;2:37-46.
91. Rapoport N. Combined cancer therapy by micellar-encapsu-lated drug and ultrasound. Int J Pharm 2004;277:155-162.
92. Rapoport N, Marin A, Luo Y, Prestwich GD, Muniruzzaman MD. Intracellular uptake and trafficking of Pluronic micelles in drug-sensitive and MDR cells: Effect on the intracellular drug localization. J Pharm Sci 2002;91:157-170.
93. Schlicher RK, Radhakrishna H, Tolentino TP, Apkarian RP, Zarnitsyn V, Prausnitz MR. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 2006; 32:915-924.
94. Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet 1999;353:1409.
95. Taniyama Y, Tachibana K, Hiraoka K, Aoki M, Yamamoto S, Matsumoto K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: Enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002;9:372-380.
96. Muniruzzaman MD, Marin A, Luo Y, Prestwich GD, Pitt WG, Husseini GA, et al. Intracellular uptake of Pluronic copolymers: Effect of the aggregation state. Colloids Surf B Biointerfaces 2002;25:233-241.
97. Rapoport N. Factors affecting ultrasound interactions with polymeric micelles and viable cells. In: Swenson S, editor. Carrier-based drug delivery. Symposium Series. Washington, DC: ACS; 2004. pp 161-173.
98. Rapoport N. Combined cancer therapy by micellar-encap-sulated drug and ultrasound. In: Amiji M, editor. Nanotechnology for cancer therapy. Boca Raton, FL: CRC Press; 2006. pp 417-437.
99. Mohan P, Rapoport N. Doxorubicin as a molecular nanotheranostic agent: Effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol Pharm 2010;7:1959-1973.
100. Lee ES, Na K, Bae YH. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release 2005;103:405-418.
101. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 2008;5:505-515.
102. Aliabadi HM, Shahin M, Brocks DR, Lavasanifar A. Disposition of drugs in block copolymer micelle delivery systems: From discovery to recovery. Clin Pharmacokinet 2008;47:619-634.
103. Oerlemans C, Bult W, Bos M, Storm G, Nijsen JF, Hennink WE. Polymeric micelles in anticancer therapy: Targeting, imaging and triggered release. Pharm Res 2010;27:2569-2589.
104. Torchilin VP. Drug targeting. Eur J Pharm Sci 2000; 11S2:S81-91.
105. Yamamoto Y, Nagasaki Y, Kato Y, Sugiyama Y, Kataoka K. Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge. J Control Release 2001;77:27-38.
106. Cho H, Indig GL, Weichert J, Shin HC, Kwon GS. In vivo cancer imaging by poly(ethylene glycol)-b-poly("-caprolac-tone) micelles containing a near-infrared probe. Nanomedicine 2012;8:228-236.
107. Cho H, Kwon GS. Polymeric micelles for neoadjuvant cancer therapy and tumor-primed optical imaging. ACS Nano 2011;5:8721-8729.
108. Diezi TA, Takemoto JK, Davies NM, Kwon GS. Pharmacokinetics and nephrotoxicity of amphotericin B-incorporated poly(ethylene glycol)-block- poly(N-hexyl stearate l-aspartamide) micelles. J Pharm Sci 2011;100: 2064-2070.
109. Kwon GS. Editorial for theme section on polymeric micelles for drug delivery. Pharm Res 2008;25:2053-2055.
110. Xiong MP, Yanez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM, et al. Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats. J Control Release 2008;129:33-40.
111. Greish K, Fang J, Inutsuka T, Nagamitsu A, Maeda H. Macromolecular therapeutics: Advantages and prospects with special emphasis on solid tumour targeting. Clin Pharmacokinet 2003;42:1089-1105.
112. Greish K, Sawa T, Fang J, Akaike T, Maeda H. SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours. J Control Release 2004;97: 219-230.
113. Rapoport NY, Kennedy AM, Shea JE, Scaife CL, Nam K-H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 2009;138:268-276.
114. Husseini GA, Diaz de la Rosa MA, Richardson ES, Christensen DA, Pitt WG. The role of cavitation in acoustically activated drug delivery. J Control Release 2005;107: 253-261.
115. Kudo N, Okada K, Yamamoto K. Sonoporation by single-shot pulsed ultrasound with microbubbles adjacent to cells. Biophys J 2009;96:4866-4876.
116. Ohl CD, Arora M, Ikink R, de Jong N, Versluis M, Delius M, et al. Sonoporation from jetting cavitation bubbles. Biophys J 2006;91:4285-4295.
117. Saito M, Mazda O, Takahashi KA, Arai Y, Kishida T, Shin-Ya M, et al. Sonoporation mediated transduction of pDNA/siRNA into joint synovium in vivo. J Orthop Res 2007;25: 1308-1316.
118. van Wamel A, Kooiman K, Harteveld M, Emmer M, ten Cate FJ, Versluis M, et al. Vibrating microbubbles poking individual cells: Drug transfer into cells via sonoporation. J Control Release 2006;112:149-155.
119. Krasovitski B, Frenkel V, Shoham S, Kimmel E. Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects. Proc Natl Acad Sci USA 2011;108:3258-3263.
120. Ogawa K, Tachibana K, Uchida T, Tai T, Yamashita N, Tsujita N, et al. High-resolution scanning electron microscopic evaluation of cell-membrane porosity by ultrasound. Med Electron Microsc 2001;34:249-253.
121. Tran TA, Le Guennec JY, Bougnoux P, Tranquart F, Bouakaz A. Characterization of cell membrane response to ultrasound activated microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control 2008;55:43-49.
122. Yudina A, Lepetit-Coiffe M, Moonen CT. Evaluation of the temporal window for drug delivery following ultrasound-mediated membrane permeability enhancement. Mol Imaging Biol 2011;13:239-249.
123. Zarnitsyn V, Rostad CA, Prausnitz MR. Modeling trans-membrane transport through cell membrane wounds created by acoustic cavitation. Biophys J 2008;95:4124-4138.
124. Cope DA, Dewhirst MW, Friedman HS, Bigner DD, Zalutsky MR. Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia. Cancer Res. 1990;50:1803-1809.
125. Fujiwara K, Watanabe T. Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability. Acta Pathol Jpn 1990;40:79-84.
126. Hosono MN, Hosono M, Endo K, Ueda R, Onoyama Y. Effect of hyperthermia on tumor uptake of radiolabeled anti-neural cell adhesion molecule antibody in small-cell lung cancer xenografts. J Nucl Med 1994;35:504-509.
127. Lefor AT, Makohon S, Ackerman NB. The effects of hyperthermia on vascular permeability in experimental liver metastasis. J Surg Oncol 1985;28:297-300.
128. Schuster JM, Zalutsky MR, Noska MA, Dodge R, Friedman HS, Bigner DD, et al. Hyperthermic modulation of radiolabelled antibody uptake in a human glioma xeno-graft and normal tissues. Int J Hyperthermia 1995;11:59-72.
129. Kruger W, Mayer WK, Schaefer C, Stohrer M, Vaupel P. Acute changes of systemic parameters in tumour-bearing rats, and of tumour glucose, lactate, and ATP levels upon local hyperthermia and/or hyperglycaemia. J Cancer Res Clin Oncol 1991;117:409-415.
130. Matsuoka H, Furusawa M, Tomoda H, Seo Y, Sugimachi K. Efficacy of indomethacin pretreatment with regional hyper-thermia for treating upper abdominal malignancies. Int J Hyperthermia 1995;11:169-171.
131. Page RL, Meyer RE, Thrall DE, Dewhirst MW. Cardiovascular and metabolic response of tumour-bearing dogs to whole body hyperthermia. Int J Hyperthermia 1987;3:513-525.
132. Chen Q, Krol A, Wright A, Needham D, Dewhirst MW, Yuan F. Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome. Int J Hyperthermia 2008;24:475-482.
133. Rapoport N, Gao Z, Kennedy A. Multifunctional nanopar-ticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 2007;99:1095-1106.
134. Rapoport N, Kennedy AM, Shea JE, Scaife CL, Nam KH. Ultrasonic nanotherapy of pancreatic cancer: Lessons from ultrasound imaging. Mol Pharm 2010;7:22-31.
135. Rapoport N, Nam K-H, Gupta R, Gao Z, Mohan P, Payne A, et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release 2011; 153:4-15.
136. Rapoport NY, Efros AL, Christensen DA, Kennedy AM, Nam KH. Microbubble generation in phase-shift nanoemul-sions used as anticancer drug carriers. Bub Sci Eng Tech 2009;1:31-39.